Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Axogen Q2 Adj. EPS $0.12 Beats $0.06 Estimate, Sales $56.66M Beat $52.64M Estimate

Author: Benzinga Newsdesk | August 05, 2025 06:03am
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.06 by 93.55 percent. This is a 140 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $56.66 million which beat the analyst consensus estimate of $52.64 million by 7.65 percent. This is a 18.26 percent increase over sales of $47.91 million the same period last year.

Posted In: AXGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist